Operating Lease, Right-of-Use Asset of NEUROCRINE BIOSCIENCES INC from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NEUROCRINE BIOSCIENCES INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • NEUROCRINE BIOSCIENCES INC Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $455,400,000, a 11% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

NEUROCRINE BIOSCIENCES INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $455,400,000 -$54,000,000 -11% 31 Dec 2025 10-K 11 Feb 2026 2025 FY
Q3 2025 $468,900,000 +$211,600,000 +82% 30 Sep 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 $492,300,000 +$229,400,000 +87% 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 $502,200,000 +$231,400,000 +85% 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 $509,400,000 +$232,900,000 +84% 31 Dec 2024 10-K 11 Feb 2026 2025 FY
Q3 2024 $257,300,000 +$176,500,000 +218% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $262,900,000 +$179,400,000 +215% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $270,800,000 +$186,400,000 +221% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $276,500,000 +$189,500,000 +218% 31 Dec 2023 10-K 10 Feb 2025 2024 FY
Q3 2023 $80,800,000 -$8,800,000 -9.8% 30 Sep 2023 10-Q 31 Oct 2023 2023 Q3
Q2 2023 $83,500,000 -$8,700,000 -9.4% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $84,400,000 -$10,300,000 -11% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $87,000,000 -$10,200,000 -10% 31 Dec 2022 10-K 09 Feb 2024 2023 FY
Q3 2022 $89,600,000 -$8,300,000 -8.5% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $92,200,000 -$8,100,000 -8.1% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $94,700,000 -$2,300,000 -2.4% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $97,200,000 +$14,400,000 +17% 31 Dec 2021 10-K 09 Feb 2023 2022 FY
Q3 2021 $97,900,000 +$26,900,000 +38% 30 Sep 2021 10-Q 01 Nov 2021 2021 Q3
Q2 2021 $100,300,000 +$28,200,000 +39% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $97,000,000 +$23,700,000 +32% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $82,800,000 +$8,500,000 +11% 31 Dec 2020 10-K 11 Feb 2022 2021 FY
Q3 2020 $71,000,000 +$9,013,000 +15% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $72,100,000 +$23,015,000 +47% 30 Jun 2020 10-Q 03 Aug 2020 2020 Q2
Q1 2020 $73,300,000 +$23,996,000 +49% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $74,300,000 +$74,300,000 31 Dec 2019 10-K 05 Feb 2021 2020 FY
Q3 2019 $61,987,000 30 Sep 2019 10-Q 04 Nov 2019 2019 Q3
Q2 2019 $49,085,000 30 Jun 2019 10-Q 29 Jul 2019 2019 Q2
Q1 2019 $49,304,000 31 Mar 2019 10-Q 29 Apr 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-Q 29 Apr 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.